Whether pharmacy benefit managers fundamentally change in the wake of the Amazon partnership with Berkshire Hathaway and JPMorgan, their link in the chain likely will not, according to Tim van Biesen, a partner with Bain & Company and a leader of their healthcare practice. "You have to manage drug benefits, because if you don't, you return all the pricing leverage back to the pharmaceutical companies," he said.